Such models could incorporate biomarker profiles (AFP, PIVKA-II), viral factors (HBV genotype, HBeAg status, HCV genotype/subgenotype), host-related parameters (liver stiffness, cirrhosis, alcohol exposure), and other clinical cofactors. This evidence concerns the gene AFP and Cirrhosis.